The present study demonstrated that a high level of MEF2A in CRC tissues increased metastasis and decreased overall survival time, and the mechanism by which MEF2A drives the malignant phenotypes of CRC were preliminary characterized. The gene discussed is MEF2A; the disease is colorectal carcinoma.